Results
Natco Pharma Q4 FY26 Net Profit Declines 34% YoY
Natco Pharma reported a 34% YoY decline in Q4 consolidated net profit to INR269 crores, including a one-time tax benefit of INR115 crores.
Management provided FY27 revenue guidance of INR3,400-3,500 c
